Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
The latest update is out from Baxter International ( (BAX) ).
On December 22, 2025, Baxter International Inc. completed the final settlement of previously announced cash tender offers targeting any and all of its 2.600% senior unsecured notes due 2026 and up to $600 million in aggregate purchase price of its 1.915% senior unsecured notes due 2027. By the early settlement date of December 8, 2025, the company had already purchased $420.589 million of the 2026 notes and $614.37 million of the 2027 notes, fully satisfying and discharging the outstanding 2026 notes and fully subscribing the 2027 note offer, with no further 2027 notes accepted thereafter; an additional $2.61 million of 2026 notes tendered by the final expiration time on December 18, 2025, were accepted at a discounted price of $960.50 per $1,000 of principal plus accrued interest, underscoring Baxter’s continued effort to actively manage and reduce its near-term debt obligations.
The most recent analyst rating on (BAX) stock is a Hold with a $19.00 price target. To see the full list of analyst forecasts on Baxter International stock, see the BAX Stock Forecast page.
Spark’s Take on BAX Stock
According to Spark, TipRanks’ AI Analyst, BAX is a Neutral.
Baxter International’s overall stock score reflects significant financial and operational challenges. The company’s high leverage, negative profitability, and cash flow issues are major concerns. While there are some positive developments, such as the issuance of senior notes and growth in certain segments, these are overshadowed by the broader financial instability and technical downtrend.
To see Spark’s full report on BAX stock, click here.
More about Baxter International
Baxter International Inc. is a global healthcare company that develops and manufactures medical products, including devices and therapies used in hospitals and clinics, with a focus on critical care, nutrition, renal care, and other essential health services.
Average Trading Volume: 7,931,621
Technical Sentiment Signal: Sell
Current Market Cap: $9.75B
For detailed information about BAX stock, go to TipRanks’ Stock Analysis page.